About the Cancer Research UK Manchester Institute
The CRUK Manchester Institute is a leading cancer research institute within The University of Manchester, spanning the whole spectrum of cancer research - from investigating the molecular and cellular basis of cancer, to translational research and the development of therapeutics.
The Institute supports a number of investigative programmes, spanning both basic and translational cancer research. It has excellent laboratory facilities and outstanding core services, including genomic sequencing, confocal microscopy, bioinformatics, histology, and access to mass-spectrometry based proteomics.
The Institute has over 400 Postdoctoral Scientists, Clinical Fellows, Scientific Officers, Operational and Technical staff, Postgraduate Research Students and Visiting Fellows. The Institute has strong links with The Christie hospital – the largest cancer centre in Europe, treating more than 40,000 patients per year.
The Manchester Cancer Research Centre (MCRC) was formed in 2006 in order to further develop links between The University of Manchester, Cancer Research UK and The Christie NHS Foundation Trust. The Cancer Research UK Manchester Institute is at the heart of the MCRC. For more information, please visit the MCRC website.
Paterson Building Fire
On 26 April 2017 the Paterson Building, which housed the majority of the CRUK Manchester Institute, suffered a major fire resulting in significant structural damage. Until our research facilities are re-established, the Institute is relocating to Alderley Park in Cheshire, one of the largest life science communities in Europe. During this period, exciting new opportunities will be exploited, whilst retaining our close links to The Christie NHS Foundation Trust as these are critical to our aims of improving the outcomes for cancer patients through research.